A Public Health perspective on getting the risks and dangers of the Ebola virus in perspective. Ebola is a serious infectious disease, and should never be taken lightly. Yet it's easy for lack of understanding of this virus to give way to fear, when what we really need to tackle it is knowledge. And an effective vaccine! FURTHER INFORMATION AND READING University of Michigan School of Public Health: http://www.sph.umich.edu/ebola/ University of Michigan Risk Science Center: http://www.riskscience.umich.edu/ebola/ Ebola facts: New York Times: http://www.nytimes.com/interactive/2014/07/31/world/africa/ebola-virus-outbreak-qa.html Why people without symptoms aren't going to give you Ebola (The Conversation): http://theconversation.com/why-people-without-symptoms-arent-going-to-give-you-ebola-33500 Centers for Disease Control and Prevention: http://www.cdc.gov/vhf/ebola/ National Library of Medicine Ebola Outbreak 2014: Information Resources: http://sis.nlm.nih.gov/dimrc/ebola_2014.html Risk Bites is supported by the ASU Risk Innovation Lab and the School for the Future of Innovation in Society Backing track: Based on Blue and Green by Rimsky. http://www.premiumbeat.com/royalty_free_music/songs/blue-and-green Risk Bites is your guide to making sense of risk. We cover everything from understanding and balancing the risks and benefits of everyday products, to health science more broadly, to the potential impacts of emerging technologies, to making sense of risk perception. If you enjoy our videos, please subscribe, and spread the word! Transcript: alugha Click here to see more videos: https://alugha.com/RiskBites
Okay so this has nothing to do with risk. Or science (sort of). But I couldn't resist making it! I love Thanksgiving. This has to be one of the best holidays, period. Negligible commercialization, great food, and a chance to relax, catch up with family and friends, and contemplate everything you
A gene drive is a radical new way of re-engineering the genetic makeup of an entire species - including harmful insects like the mosquito. But as the technology steams head, fueled by powerful gene editing techniques coming out of synthetic biology like CRISPR Cas9, what are the risks, and how can w
Advanced brain computer interfaces like the one being developed by Elon Musk’s Neuralink have the potential to transform our lives for the better. But they also come with complex ethical challenges. In this collaboration with Elma Hajric, Risk Bites dives into some of ethical risks and responsible
